Author, year of publication No. of cases Gender Age (years) Disease presentation Treatment Outcome Sailer et al., 1997 [7 ] 1 F 6 Immunocompromised (HIV) ABZ 15 mg/kg/day intermittently Progression—new intrahepatic lesion, later unknown Kinčekova et al., 2008 [8 ] 1 F 14 Headache, fatigue, cough, fever, hepatomegaly, 12.5 × 12.3 cm lesion in the right lobe of the liver with numerous calcifications ABZ 10 mg/kg/day and partial hepatectomy Progress after 1 year of ABZ alone, negative IgG at 3 months after surgery Honda et al., 2009 [9 ] 1 F 9 Fever, general fatigue, nausea, 5.0 × 6.0 cm multilobular mass + masses between diaphragm and right lobe of the liver Partial hepatectomy + diaphragm and abdominal wall resection ABZ 160 mg/day since surgery Alive, no signs of recurrence during 15 months of follow-up Yoshida et al., 2010 [10 ] 9 6 F 7 to 15 2 had abdominal pain and hepatomegaly, 1 had liver dysfunction, and 6 were asymptomatic, diagnosed during mass screening Partial hepatectomy in 8 patients 1 patient died of liver failure (lesions were unresectable), 1 had reresection after 4 years and 7 patients survived up to 33 years without recurrence Oral et al., 2012 [5 ] 1 F 12 Jaundice, weight loss, abdominal distension, 13 cm mass in the liver ABZ 10 mg/kg/day + LT Alive Nahorski et al., 2013 [11 ] 4 N/A 6–11 N/A ABZ in 3 patients ABZ + hepatectomy in 1 patient N/A Kantarci et al., 2014 [12 ] 1 M 15 Epilepsy and headaches, 18 × 11 cm lesion in the left and partially right lobe of the liver, invading the portal vein and inferior vena cava + left frontotemporal mass and cavitary lesion in the right lung Life-long treatment with ABZ 10 mg/kg/day N/A Mack et al., 2019 [13 ] 1 M 12 Left flank pain, extensive lesion from S5/6 to S8 with stenosis of portal vein ABZ 8 mg/kg/day Lesion decreased
